CN103462968B - Incarviatone A在制备抗细菌药物中的应用 - Google Patents

Incarviatone A在制备抗细菌药物中的应用 Download PDF

Info

Publication number
CN103462968B
CN103462968B CN201310432740.8A CN201310432740A CN103462968B CN 103462968 B CN103462968 B CN 103462968B CN 201310432740 A CN201310432740 A CN 201310432740A CN 103462968 B CN103462968 B CN 103462968B
Authority
CN
China
Prior art keywords
incarviatone
preparing
bacterial drug
belongs
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310432740.8A
Other languages
English (en)
Other versions
CN103462968A (zh
Inventor
刘岩
李俊珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liu Yan
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310432740.8A priority Critical patent/CN103462968B/zh
Publication of CN103462968A publication Critical patent/CN103462968A/zh
Application granted granted Critical
Publication of CN103462968B publication Critical patent/CN103462968B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明涉及Incarviatone？A在制备抗细菌药物中的应用，属于医药领域。Incarviatone？A具有很强的抑制大肠杆菌、荧光假单孢菌、金黄色葡萄球、变形杆菌、新生隐球菌的作用，因此Incarviatone？A可作为具有抗细菌的化合物，并有望在制备相关药物中得到应用。本发明涉及的Incarviatone？A在制备抗细菌药物中的用途属于首次公开，由于骨架类型属于全新的骨架类型，而且其对于细菌抑制活性强得意想不到，不存在由其他化合物给出任何启示的可能，具备突出的实质性特点，同时用于细菌感染的防治显然具有显著的进步。

Description

Incarviatone A在制备抗细菌药物中的应用
技术领域
本发明涉及IncarviatoneA的用途，尤其涉及IncarviatoneA在制备抗细菌药物中的应用。
背景技术
致病菌的扩散及其耐药性的增强严重威胁着人类的健康和生命，抗菌药物已作为常规用药广泛用于艾滋病、器官移植以及慢性消耗性疾病(如癌症、糖尿病、尿毒症等)的治疗，虽然目前临床上使用的抗菌药剂(如酮康唑、阿米卡星、庆大霉素、活力康唑、伊曲康唑、特比萘芬、二性霉素、氟康唑等)对皮肤及浅表部位感染的疗效较好，但这些抗菌药物的蓄积毒性较强，常常引起肝肾损伤、消化道刺激、头晕、过敏等，所以寻找作用机理独特的新型抗菌药物成为当今药物研发的热点之一。
本发明涉及的化合物IncarviatoneA是一个2012年发表(Shen,Y.H.etal.,2012.IncarviatoneA,astructurallyuniquenaturalproducthybridwithanewcarbonskeletonfromIncarvilleadelavayi,anditsabsoluteconfigurationviacalculatedelectroniccirculardichroicspectra.RSCAdvances2,4175–4180.)的新骨架化合物，该化合物拥有全新的骨架类型，目前没有关于该化合物活性方面的报道，对于本发明涉及的IncarviatoneA在制备抗细菌药物中的用途属于首次公开，由于骨架类型属于全新的骨架类型，而且其对于细菌抑制活性强得意想不到，不存在由其他化合物给出任何启示的可能，具备突出的实质性特点，同时用于细菌感染的防治显然具有显著的进步。
发明内容
本发明的目的在于：
提供一种本发明的IncarviatoneA在制备抗细菌药物中的应用。
所述化合物IncarviatoneA结构如式(Ⅰ)所示：
IncarviatoneA具有很强的抑制大肠杆菌、荧光假单孢菌、金黄色葡萄球、变形杆菌、新生隐球菌的作用，所以IncarviatoneA可作为具有抗菌作用的化合物，并有望在制备抗菌药物中得到应用。
IncarviatoneA在制备抗细菌药物中的用途属于首次公开，由于骨架类型属于全新的骨架类型，而且其对于细菌抑制活性强得意想不到，不存在由其他化合物给出任何启示的可能，具备突出的实质性特点，同时用于细菌感染的防治显然具有显著的进步。
具体实施方式
本发明所涉及化合物IncarviatoneA的制备方法参见文献(Shen,Y.H.etal.,2012.IncarviatoneA,astructurallyuniquenaturalproducthybridwithanewcarbonskeletonfromIncarvilleadelavayi,anditsabsoluteconfigurationviacalculatedelectroniccirculardichroicspectra.RSCAdvances2,4175–4180.)。
以下通过实施例对本发明作进一步详细的说明，但本发明的保护范围不受具体实施例的任何限制，而是由权利要求加以限定。
实施例1：本发明所涉及化合物IncarviatoneA片剂的制备：
取20克化合物IncarviatoneA，加入制备片剂的常规辅料180克，混匀，常规压片机制成1000片。
实施例2：本发明所涉及化合物IncarviatoneA胶囊剂的制备：
取20克化合物IncarviatoneA，加入制备胶囊剂的常规辅料如淀粉180克，混匀，装胶囊制成1000片。
下面通过药效学实验来进一步说明其药物活性。
实验例：IncarviatoneA抗菌活性
抗菌活性实验是采用浓度稀释的方法，每次测定重复三次，测试病原菌有大肠杆菌、荧光假单孢菌、金黄色葡萄球、变形杆菌、新生隐球菌，菌液浓度为105个/mL。IncarviatoneA起始浓度为50.0μg/mL(5％二甲基亚砜DMSO)，梯度稀释至0.098μg/mL，等量体积的菌液和测试样品混合培养在96孔板中，细菌培养温度分别为37℃，培养时间24h后观察，若发现没有菌落形成时为样品最低抗菌浓度，即MIC值。该实验阳性对照为硫酸阿米卡星，IncarviatoneA抗菌结果见表1。
表1IncarviatoneA抗菌MIC值(μg/mL)
结论：IncarviatoneA具有很强的抗细菌活性，因此本发明的IncarviatoneA有望被用于制备新型抗菌药物。

Claims (1)

1.IncarviatoneA在制备抗细菌药物中的应用，所述化合物IncarviatoneA结构如式（Ⅰ）所示：
式（Ⅰ）。
CN201310432740.8A 2013-09-22 2013-09-22 Incarviatone A在制备抗细菌药物中的应用 Expired - Fee Related CN103462968B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310432740.8A CN103462968B (zh) 2013-09-22 2013-09-22 Incarviatone A在制备抗细菌药物中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310432740.8A CN103462968B (zh) 2013-09-22 2013-09-22 Incarviatone A在制备抗细菌药物中的应用

Publications (2)

Publication Number Publication Date
CN103462968A CN103462968A (zh) 2013-12-25
CN103462968B true CN103462968B (zh) 2015-11-25

Family

ID=49788166

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310432740.8A Expired - Fee Related CN103462968B (zh) 2013-09-22 2013-09-22 Incarviatone A在制备抗细菌药物中的应用

Country Status (1)

Country Link
CN (1) CN103462968B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104083377B (zh) * 2014-06-25 2016-12-28 顾玉奎 闭花木酮Cleistanone的二甲胺衍生物在制备抗菌药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021496A2 (en) * 2003-08-27 2005-03-10 The Trustees Of Columbia University In The City Of New York Synthesis of derivatives of ginkgolide c
EP1939166A1 (en) * 2006-12-19 2008-07-02 InterMed Discovery GmbH Plants extracts for use in brain modulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021496A2 (en) * 2003-08-27 2005-03-10 The Trustees Of Columbia University In The City Of New York Synthesis of derivatives of ginkgolide c
EP1939166A1 (en) * 2006-12-19 2008-07-02 InterMed Discovery GmbH Plants extracts for use in brain modulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ncarviatone A,a structurally unique natural product hybrid with a new carbon skeleton from Incarvillea delavayi,and its absolute configuration via calculated electronic circular dichroic spectra;Shen,Y.H.et al.,;《RSC ADVANCES2》;20121231;4175-4180 *

Also Published As

Publication number Publication date
CN103462968A (zh) 2013-12-25

Similar Documents

Publication Publication Date Title
CN103462968B (zh) Incarviatone A在制备抗细菌药物中的应用
CN103446125B (zh) Lycojaponicumin B在制备抗细菌药物中的应用
CN103251611A (zh) Aspeverin在制备抗细菌药物中的应用
CN102872090B (zh) Houttuynoid B在制备抗细菌药物中的应用
CN103463037B (zh) Lycojaponicumin A在制备抗细菌药物中的应用
CN102872105B (zh) Houttuynoid C在抗细菌药物中的应用
CN103381164B (zh) Chukrasone A在制备抗细菌药物中的应用
CN103463075B (zh) Lycojaponicumin C在制备抗细菌药物中的应用
CN103381153B (zh) Chukrasone B在制备抗细菌药物中的应用
CN102861076B (zh) Houttuynoid A在制备抗细菌药物中的应用
CN102872030B (zh) Gypensapogenin B在制备抗细菌药物中的应用
CN102895238B (zh) Gypensapogenin A在抗细菌药物中的应用
CN103446114A (zh) Sarcaboside A在抗细菌药物中的应用
CN103356517B (zh) Scopariusins在制备抗细菌药物中的应用
CN103462982B (zh) Spirooliganones B在制备抗细菌药物中的应用
CN103446135B (zh) Lycojaponicumin A在制备抗人体真菌药物中的应用
CN105412091A (zh) Daphnilongeranine C在制备抗细菌药物中的应用
CN103479636B (zh) Lycojaponicumin C在制备抗人体真菌药物中的应用
CN103027907A (zh) Aphanamixoid A在制备抗细菌药物中的应用
CN102895251A (zh) Houttuynoid E在抗细菌药物中的应用
CN103638010B (zh) Artoxanthochromane在制备抗细菌药物中的应用
CN102872146A (zh) Houttuynoid D在抗细菌药物中的应用
CN103463029B (zh) Lycojaponicumin B在制备抗人体真菌药物中的应用
CN103446106A (zh) Sarcaboside B在抗细菌药物中的应用
CN103372004B (zh) Chukrasone B在制备抗人体真菌药物中的应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
CB03 Change of inventor or designer information

Inventor after: Liu Yan

Inventor after: Li Junshan

Inventor before: Jiang Chunping

Inventor before: Huang Rong

COR Change of bibliographic data
TA01 Transfer of patent application right

Effective date of registration: 20151020

Address after: 257400 Shandong city of Dongying province Lijin County Zhen Zheng and Yan Wo Street No. 7

Applicant after: Liu Yan

Address before: Metro Technology Building No. 69 Olympic Avenue in Jianye District of Nanjing city in Jiangsu province 210019 01 5 storey buildings

Applicant before: Nanjing Guangkangxie Biomedical Technology Co., Ltd.

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20190922